{"id":"https://openalex.org/W2073748481","doi":"https://doi.org/10.1097/qad.0b013e3283112b8e","title":"The 3-year renal safety of a tenofovir disoproxil fumarate vs. a thymidine analogue-containing regimen in antiretroviral-naive patients","display_name":"The 3-year renal safety of a tenofovir disoproxil fumarate vs. a thymidine analogue-containing regimen in antiretroviral-naive patients","publication_year":2008,"publication_date":"2008-10-02","ids":{"openalex":"https://openalex.org/W2073748481","doi":"https://doi.org/10.1097/qad.0b013e3283112b8e","mag":"2073748481","pmid":"https://pubmed.ncbi.nlm.nih.gov/18832879"},"language":"en","primary_location":{"id":"doi:10.1097/qad.0b013e3283112b8e","doi":"https://doi.org/10.1097/qad.0b013e3283112b8e","is_oa":false,"landing_page_url":"https://doi.org/10.1097/qad.0b013e3283112b8e","pdf_url":null,"source":{"id":"https://openalex.org/S20605092","display_name":"AIDS","issn_l":"0269-9370","issn":["0269-9370","1473-5571"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5048477426","display_name":"Joel E. Gallant","orcid":"https://orcid.org/0000-0002-7144-1642","observed_orcids":["https://orcid.org/0000-0002-7144-1642"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joel E Gallant","raw_affiliation_strings":["Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johns Hopkins University School of Medicine, Baltimore, Maryland, USA","institution_ids":["https://openalex.org/I145311948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109900415","display_name":"Jonathan A. Winston","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I98704320","display_name":"Icahn School of Medicine at Mount Sinai","ror":"https://ror.org/04a9tmd77","country_code":"US","type":"education","lineage":["https://openalex.org/I1320796813","https://openalex.org/I98704320"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jonathan A Winston","raw_affiliation_strings":["Mount Sinai School of Medicine, New York, New York, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mount Sinai School of Medicine, New York, New York, USA","institution_ids":["https://openalex.org/I98704320"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103806974","display_name":"Edwin DeJesus","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210120784","display_name":"Orlando Immunology Center","ror":"https://ror.org/02cj88v79","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210120784"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Edwin DeJesus","raw_affiliation_strings":["Orlando Immunology Center, Orlando, Florida, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Orlando Immunology Center, Orlando, Florida, USA","institution_ids":["https://openalex.org/I4210120784"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048050447","display_name":"Anton Pozniak","orcid":"https://orcid.org/0000-0002-4091-5323","observed_orcids":["https://orcid.org/0000-0002-4091-5323"]},"institutions":[{"id":"https://openalex.org/I4210136304","display_name":"Chelsea and Westminster Hospital","ror":"https://ror.org/038zxea36","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2799869770","https://openalex.org/I4210136304"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Anton L Pozniak","raw_affiliation_strings":["Chelsea and Westminster Hospital, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chelsea and Westminster Hospital, London, UK","institution_ids":["https://openalex.org/I4210136304"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109168426","display_name":"Shan-Shan Chen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shan-Shan Chen","raw_affiliation_strings":["Gilead Sciences, Foster City, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gilead Sciences, Foster City, California, USA","institution_ids":["https://openalex.org/I4210140816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001632717","display_name":"Andrew Cheng","orcid":"https://orcid.org/0000-0002-1121-8051","observed_orcids":["https://orcid.org/0000-0002-1121-8051"]},"institutions":[{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew K Cheng","raw_affiliation_strings":["Gilead Sciences, Foster City, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gilead Sciences, Foster City, California, USA","institution_ids":["https://openalex.org/I4210140816"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5074748590","display_name":"Jeffrey Enejosa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jeffrey V Enejosa","raw_affiliation_strings":["Gilead Sciences, Foster City, California, USA","to Jeffrey Enejosa, MD, Gilead Sciences, 300 Lakeside Drive, Foster City, CA 94404, USA. Tel: +1 650 522 5082; fax: +1 650 522 5595; e-mail: [email\u00a0protected]","e-mail: [email\u00a0protected]","fax: +1 650 522 5595","to Jeffrey Enejosa, MD, Gilead Sciences, 300 Lakeside Drive, Foster City, CA 94404, USA. Tel: +1 650 522 5082"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gilead Sciences, Foster City, California, USA","institution_ids":["https://openalex.org/I4210140816"]},{"raw_affiliation_string":"to Jeffrey Enejosa, MD, Gilead Sciences, 300 Lakeside Drive, Foster City, CA 94404, USA. Tel: +1 650 522 5082; fax: +1 650 522 5595; e-mail: [email\u00a0protected]","institution_ids":["https://openalex.org/I4210140816"]},{"raw_affiliation_string":"e-mail: [email\u00a0protected]","institution_ids":[]},{"raw_affiliation_string":"fax: +1 650 522 5595","institution_ids":[]},{"raw_affiliation_string":"to Jeffrey Enejosa, MD, Gilead Sciences, 300 Lakeside Drive, Foster City, CA 94404, USA. Tel: +1 650 522 5082","institution_ids":["https://openalex.org/I4210140816"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5074748590"],"corresponding_institution_ids":["https://openalex.org/I4210140816"],"apc_list":null,"apc_paid":null,"fwci":9.6631,"has_fulltext":false,"cited_by_count":125,"citation_normalized_percentile":{"value":0.98506101,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"22","issue":"16","first_page":"2155","last_page":"2163"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11655","display_name":"HIV-related health complications and treatments","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2711","display_name":"Emergency Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tenofovir-disoproxil-fumarate","display_name":"tenofovir disoproxil fumarate","score":1.0},{"id":"https://openalex.org/keywords/renal-safety","display_name":"renal safety","score":0.8510000109672546},{"id":"https://openalex.org/keywords/hiv-infection","display_name":"HIV infection","score":0.7820000052452087},{"id":"https://openalex.org/keywords/antiretroviral-naive-patients","display_name":"antiretroviral-naive patients","score":0.9890000224113464},{"id":"https://openalex.org/keywords/stavudine","display_name":"stavudine","score":0.8700000047683716},{"id":"https://openalex.org/keywords/zidovudine","display_name":"zidovudine","score":1.0},{"id":"https://openalex.org/keywords/efavirenz","display_name":"efavirenz","score":0.8980000019073486},{"id":"https://openalex.org/keywords/lamivudine","display_name":"lamivudine","score":0.9729999899864197},{"id":"https://openalex.org/keywords/emtricitabine","display_name":"emtricitabine","score":1.0},{"id":"https://openalex.org/keywords/glomerular-filtration-rate","display_name":"glomerular filtration rate","score":0.9010000228881836},{"id":"https://openalex.org/keywords/serum-creatinine","display_name":"serum creatinine","score":0.9039999842643738},{"id":"https://openalex.org/keywords/serum-phosphorus","display_name":"serum phosphorus","score":0.9580000042915344},{"id":"https://openalex.org/keywords/proteinuria","display_name":"proteinuria","score":0.9240000247955322},{"id":"https://openalex.org/keywords/nephrotoxicity","display_name":"nephrotoxicity","score":0.9340000152587891}],"concepts":[{"id":"https://openalex.org/C159641895","wikidata":"https://www.wikidata.org/wiki/Q108377937","display_name":"Renal function","level":2,"score":0.8147252798080444},{"id":"https://openalex.org/C2781432083","wikidata":"https://www.wikidata.org/wiki/Q422645","display_name":"Efavirenz","level":5,"score":0.7948299646377563},{"id":"https://openalex.org/C2780216070","wikidata":"https://www.wikidata.org/wiki/Q198504","display_name":"Zidovudine","level":4,"score":0.7529489994049072},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7228378057479858},{"id":"https://openalex.org/C2777869810","wikidata":"https://www.wikidata.org/wiki/Q422631","display_name":"Lamivudine","level":4,"score":0.7123263478279114},{"id":"https://openalex.org/C2779778239","wikidata":"https://www.wikidata.org/wiki/Q422604","display_name":"Emtricitabine","level":5,"score":0.6990171074867249},{"id":"https://openalex.org/C2780306776","wikidata":"https://www.wikidata.org/wiki/Q426660","display_name":"Creatinine","level":2,"score":0.6912547945976257},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.6175743341445923},{"id":"https://openalex.org/C2779889181","wikidata":"https://www.wikidata.org/wiki/Q423984","display_name":"Stavudine","level":5,"score":0.6039122343063354},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.57279372215271},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.5477003455162048},{"id":"https://openalex.org/C2778653478","wikidata":"https://www.wikidata.org/wiki/Q1054718","display_name":"Kidney disease","level":2,"score":0.4714556634426117},{"id":"https://openalex.org/C2779561371","wikidata":"https://www.wikidata.org/wiki/Q570197","display_name":"Proteinuria","level":3,"score":0.4671914577484131},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4578927457332611},{"id":"https://openalex.org/C2911190787","wikidata":"https://www.wikidata.org/wiki/Q22075912","display_name":"Tenofovir alafenamide","level":5,"score":0.45498764514923096},{"id":"https://openalex.org/C2780091579","wikidata":"https://www.wikidata.org/wiki/Q9377","display_name":"Kidney","level":2,"score":0.3151523768901825},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.2217891812324524},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.16022124886512756},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.1534532606601715},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.08389508724212646},{"id":"https://openalex.org/C2780727368","wikidata":"https://www.wikidata.org/wiki/Q1928978","display_name":"Viral disease","level":3,"score":0.07771071791648865},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.06290963292121887},{"id":"https://openalex.org/C2780593183","wikidata":"https://www.wikidata.org/wiki/Q6844","display_name":"Hepatitis B virus","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000068698","descriptor_name":"Tenofovir","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000225","descriptor_name":"Adenine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D000225","descriptor_name":"Adenine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003404","descriptor_name":"Creatinine","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005919","descriptor_name":"Glomerular Filtration Rate","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010758","descriptor_name":"Phosphorus","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D011507","descriptor_name":"Proteinuria","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D015215","descriptor_name":"Zidovudine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D018119","descriptor_name":"Stavudine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D018894","descriptor_name":"Reverse Transcriptase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D023241","descriptor_name":"Antiretroviral Therapy, Highly Active","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D063065","descriptor_name":"Organophosphonates","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1097/qad.0b013e3283112b8e","doi":"https://doi.org/10.1097/qad.0b013e3283112b8e","is_oa":false,"landing_page_url":"https://doi.org/10.1097/qad.0b013e3283112b8e","pdf_url":null,"source":{"id":"https://openalex.org/S20605092","display_name":"AIDS","issn_l":"0269-9370","issn":["0269-9370","1473-5571"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS","raw_type":"journal-article"},{"id":"pmid:18832879","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18832879","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS (London, England)","raw_type":"Clinical Trial, Phase III"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8299999833106995}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":27,"referenced_works":["https://openalex.org/W1550111394","https://openalex.org/W1968789632","https://openalex.org/W1977072157","https://openalex.org/W1978655258","https://openalex.org/W1978696458","https://openalex.org/W1994059773","https://openalex.org/W1996313031","https://openalex.org/W2004567313","https://openalex.org/W2005270107","https://openalex.org/W2008772631","https://openalex.org/W2026158691","https://openalex.org/W2055483238","https://openalex.org/W2055864845","https://openalex.org/W2055922999","https://openalex.org/W2056779298","https://openalex.org/W2060620867","https://openalex.org/W2079617435","https://openalex.org/W2094013521","https://openalex.org/W2107027814","https://openalex.org/W2114019720","https://openalex.org/W2129025092","https://openalex.org/W2140648515","https://openalex.org/W2142285241","https://openalex.org/W2142982724","https://openalex.org/W2151425917","https://openalex.org/W2161193921","https://openalex.org/W2487377689"],"related_works":["https://openalex.org/W2010542260","https://openalex.org/W2142285241","https://openalex.org/W1987818325","https://openalex.org/W2766583960","https://openalex.org/W13623729","https://openalex.org/W2016594064","https://openalex.org/W1987159522","https://openalex.org/W2162761942","https://openalex.org/W7097289595","https://openalex.org/W3032206360"],"abstract_inverted_index":{"BACKGROUND:":[0],"Cases":[1],"of":[2,20,143,169,211],"renal":[3,18,45,132,214,246,265,268],"dysfunction":[4],"in":[5,35,44,47,61,77,134,149,163,190,213,216,234,253,270],"patients":[6,49,89,144,170,255],"receiving":[7],"tenofovir":[8],"disoproxil":[9],"fumarate":[10],"(TDF)":[11],"have":[12],"been":[13],"reported.":[14],"We":[15,40],"analyzed":[16],"the":[17,42,135,141,217],"safety":[19,269],"TDF":[21,71,136,218,258],"compared":[22],"with":[23,79,90,257],"thymidine":[24],"analogue-containing":[25],"(control)":[26],"regimens":[27],"through":[28,259],"144":[29,139,189,260],"weeks":[30],"from":[31,185],"two":[32,62,228],"clinical":[33,277],"trials":[34,65],"antiretroviral-naive":[36,254],"HIV-infected":[37],"patients.":[38],"METHODS:":[39],"evaluated":[41],"changes":[43],"parameters":[46],"1111":[48],"(TDF,":[50,178],"n":[51,55],"=":[52,56],"556;":[53],"control,":[54,180],"555)":[57],"who":[58,145],"were":[59,123,240,251],"enrolled":[60],"randomized,":[63,229],"controlled":[64,230],"(Studies":[66],"903":[67],"and":[68,81,103,113,196,201,203,219,267],"934)":[69],"comparing":[70],"vs.":[72],"either":[73,82],"stavudine":[74],"or":[75,84,154,248],"zidovudine":[76],"combination":[78],"efavirenz":[80],"lamivudine":[83],"emtricitabine.":[85],"The":[86,182],"studies":[87,263],"included":[88],"serum":[91,97,150,155],"creatinine":[92,151],"less":[93,160],"than":[94,161],"1.5":[95],"mg/dl,":[96],"phosphorus":[98,156],"at":[99,110,114,118,174],"least":[100,111,115,175],"2.2":[101],"mg/dl":[102,177],"estimated":[104],"glomerular":[105,191,235],"filtration":[106,192,236],"rate":[107,193,237],"by":[108,199,209],"Cockcroft-Gault":[109],"60":[112],"50":[116],"ml/min":[117,198,205],"screening.":[119],"RESULTS:":[120],"Baseline":[121],"characteristics":[122],"similar":[124,167],"between":[125],"groups.":[126],"No":[127],"patient":[128],"discontinued":[129],"due":[130],"to":[131,187],"abnormalities":[133,148],"arm.":[137],"Through":[138],"weeks,":[140],"proportion":[142,168],"experienced":[146,171],"confirmed":[147],"(>1.5":[152],"mg/dl)":[153,158],"(<2.0":[157],"was":[159,194],"1%":[162],"both":[164],"groups;":[165],"a":[166],"urine":[172],"proteinuria":[173],"100":[176],"5%;":[179],"6%).":[181],"median":[183],"change":[184],"baseline":[186],"week":[188],"-2":[195,202],"3":[197],"Cockcroft-Gault,":[200],"-1":[204],"per":[206],"1.73":[207],"m":[208],"modification":[210],"diet":[212],"disease":[215,247],"control":[220],"groups":[221],"(P":[222],"<":[223],"0.05),":[224],"respectively.":[225],"CONCLUSION:":[226],"In":[227],"trials,":[231],"small":[232],"differences":[233],"over":[238],"time":[239],"noted":[241],"but":[242],"no":[243],"clinically":[244],"relevant":[245],"adverse":[249],"events":[250],"demonstrated":[252],"treated":[256],"weeks.":[261],"Additional":[262],"on":[264],"health":[266],"HIV":[271],"are":[272],"important":[273],"goals":[274],"for":[275],"future":[276],"trials.":[278]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":8},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":10},{"year":2015,"cited_by_count":9},{"year":2014,"cited_by_count":10},{"year":2013,"cited_by_count":11},{"year":2012,"cited_by_count":13}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}